Showing results (181-190 of 398) with videos related to

Sort By:
Pageof 40
Vascular Health and Risk Management|June 9, 2016
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS studySylvia Haas, Gerlind Holberg, Reinhold Kreutz, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|June 1, 2022
Assessing protected area vulnerability to climate change in a case study of South African national parksKevin M Coldrey, Jane K Turpie, Guy Midgley, et al.
The Canadian Journal of Cardiology|March 19, 2005
Digoxin prescribing for heart failure in elderly residents of long-term care facilitiesBrian Misiaszek, George A Heckman, Fatima Merali, et al.
Archives of Internal Medicine|January 10, 1994
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparinM N Levine, J Hirsh, M Gent, et al.
The New England Journal of Medicine|November 4, 1993
A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatientsH Heijboer, H R Büller, A W Lensing, et al.
British Journal of Haematology|February 1, 1982
Plasma betathromboglobulin and serum fragment E in acute partial strokeA C de Boer, A G Turpie, R W Butt, et al.
Vascular Medicine (London, England)|July 10, 2007
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?Alexander T Cohen, Alexander G G Turpie, Alain Leizorovicz, et al.
The Canadian Journal of Cardiology|August 28, 2004
Management of heart failure in Canadian long-term care facilitiesGeorge A Heckman, Brian Misiaszek, Fatima Merali, et al.
Thrombosis and Haemostasis|January 5, 2005
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patientsPaul T Vaitkus, Alain Leizorovicz, Alexander T Cohen, et al.
Circulation|August 4, 2004
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patientsAlain Leizorovicz, Alexander T Cohen, Alexander G G Turpie, et al.
Pageof 40